Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2012 |
| Author/s |
author: Olga S Samoilova Kudrat M Abdulkadyrov Athanasios Dimopoulos Antonio Palumbo Ivan Špička Ofer Shpilberg William Deraedt Maria Teresa Petrucci Anna Dmoszyńska Michel Delforge María Victoria Mateos Helgi van de Velde Paul G. Richardson Kenneth C. Anderson Nuriet K Khuageva Dixie-Lee Esseltine Andrew Cakana |
| Publication date | December 10, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |